nnn

Roots Analysis has announced the addition of "Medical Device CROs Market, 2018-2030" report to its list of offerings.

Roots Analysis has announced the addition of the "Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions.

Roots Analysis has announced the addition of HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition) report to its portfolio.

Roots Analysis has announced the addition of "Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030" report to its list of offerings.

Roots Analysis has announced the addition of "RNAi Therapeutics Market (2nd Edition), 2019-2030" report to its list of offerings.

The success of CTLA4, PD-1, and PD-L1 inhibitors paved the way for researchers to explore the vast therapeutic potential of immune checkpoint modulation, enabling the discovery of product candidates against clinical conditions beyond oncology

Roots Analysis has announced the addition of the "Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030" report to its list of offerings.

Roots Analysis has announced the addition of "Automotive Lithium-Ion Battery Market, 2019-2030" report to its list of offerings.

The approval of KYMRIAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field.

The success of CTLA4, PD-1, and PD-L1 inhibitors paved the way for researchers to explore the vast therapeutic potential of immune checkpoint modulation, enabling the discovery of product candidates against clinical conditions beyond oncology